Baylor College of Medicine Cancer Center

贝勒医学院癌症中心

• 批准号: 7919794
• 负责人: C KENT OSBORNE
• 金额: $ 24.56万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-07-01 至 2010-09-19
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7919794
• 关键词: Ambulatory Care Facilities; Area; Biometry; Cancer Biology; Cancer Center; Cancer Center Support Grant; Cancer Trials Support Unit; Cities; Clinic; Clinical; Collaborations; Communities; Community Actions; Community Outreach; Complex; Country; Development; Endowment; Ensure; Environment; Family; Fostering; Funding; Future; General Hospitals; Genomic Instability; Gifts; Grant; Hospitals; Institution; Lead; Leadership; Malignant Childhood Neoplasm; Malignant Neoplasms; Malignant neoplasm of pancreas; Malignant neoplasm of prostate; Medical center; Medicine; Molecular Carcinogenesis; NCI-Designated Cancer Center; Nuclear Receptors; Pathology; Patients; Pediatric Hospitals; Population Heterogeneity; Process; Research; Resource Sharing; Resources; Texas; Tissue Banking; Tissue Banks; Translating; Translational Research; Veterans; authority; base; cancer cell; cancer genomics; cancer prevention; college; gene therapy; health disparity; malignant breast neoplasm; member; multidisciplinary; organizational structure; outreach; programs; stem cell biology

DESCRIPTION (provided by applicant): This is the initial application of the Baylor College of Medicine Cancer Center (BCMCC) for NCI designation and is being submitted in the 3rd year of an NCI P20 planning grant. Baylor College of Medicine (BCM) is located in the Texas Medical Center (TMC) in Houston, the largest and perhaps most complex medical center in the country with 40 member institutions. Houston is the 4th largest city in the US with a very diverse population. The BCMCC is a consortium cancer center with BCM as the lead partner, and our four hospital affiliates, Texas Children's Hospital, St. Luke's Episcopal Hospital, The DeBakey Veterans Affairs Medical Center, and Ben Taub General Hospital, as formal clinical partners. In addition, as part of a BCM strategy to create its own ambulatory care facilities, the BCMCC is leading the planning for a comprehensive multidisciplinary cancer clinic to be completed in 2008. The BCMCC was formally established in 2002 to integrate the already strong and organized scientific and clinical programs at BCM and our partners, and to create new synergies and programs that take advantage of this unique environment. The unique environment of the TMC creates many opportunities for scientific, clinical, and educational collaborations, of which the BCMCC takes full advantage. The BCMCC has been given the resources and authority to be successful at this task and has made exciting progress over the past three years. It now includes over 260 formal members, and total annual cancer-relevant research funding documented in this proposal approaches $100 million, with close to $40 million coming from the NCI. The 8 research and translational Programs that were organized through the P-20 process remain in place and are growing stronger. These Programs are Cancer Biology, Molecular Carcinogenesis, Nuclear Receptors, Breast Cancer, Cancer Cell and Gene Therapy, Prostate Cancer, Cancer Prevention, and Pediatric Cancer. In addition, although relatively new, the Center has already fostered interactions among its members that have led to several developing research programs including pancreas cancer, genomic instability, and stem cell biology among others. In addition 9 Shared Research Resources are included in this application; 6 based on strong-capabilities present at BCM, and 3 (Biostatistics, the Clinical Trials Support Unit, and Pathology and Tissue Banking), created through BCMCC leadership and/or funding. The Center has also established an Office of Outreach and Health Disparities to better translate our extensive research expertise in this area into more coordinated community action among our partners and colleagues in the TMC and the region. Finally, the BCMCC has been recently blessed with a $100 million philanthropic gift from a wonderful Houston family. This gift has been entirely dedicated to support the development of the Center, its programs and its members and to foster collaboration with other institutions. Substantial funds will be available for use in the next year even as a long term endowment is created to ensure future stability. Thus, the CCSG outlines an organizational structure, outstanding leadership, integrated scientific research programs, expert Shared Resources, a process for community outreach, adequate and diverse patient resources, and the institutional support to build an outstanding NCI-designated Cancer Center that will benefit the Houston Community and region.

描述（由申请人提供）：这是贝勒医学癌症中心（BCMCC）的初步应用NCI指定，并在NCI P20计划赠款的第三年提交。贝勒医学院（BCM）位于休斯敦的德克萨斯医学中心（TMC），休斯敦是该国最大，最复杂的医疗中心，拥有40个会员机构。 Houston is the 4th largest city in the US with a very diverse population. BCMCC是BCM的财团癌症中心，作为首席伙伴，我们的四家医院分支机构，德克萨斯儿童医院，圣卢克主教医院，Debakey退伍军人事务医疗中心和Ben Taub综合医院作为正式的临床伙伴。此外，作为建立自己的门诊护理设施的BCM策略的一部分，BCMCC正在领导计划在2008年完成全面的多学科癌症诊所。BCMCC于2002年正式建立，以整合已经强大而有组织的科学和临床计划，以在BCM和我们的合作伙伴以及我们的合作伙伴以及创建新的环境中，以实现这一领域，以实现这一领域，以实现这一领域，以实现这一领域和这个独特的环境。 TMC的独特环境为科学，临床和教育合作创造了许多机会，BCMCC充分利用了它。 The BCMCC has been given the resources and authority to be successful at this task and has made exciting progress over the past three years.它现在包括260多名正式成员，该提案中记录的年度与癌症的总研究资金接近1亿美元，近4000万美元来自NCI。 The 8 research and translational Programs that were organized through the P-20 process remain in place and are growing stronger.这些程序是癌症生物学，分子癌变，核受体，乳腺癌，癌细胞和基因治疗，前列腺癌，预防癌症和小儿癌。 In addition, although relatively new, the 中心已经促进了其成员之间的相互作用，这导致了一些正在开发的研究计划，包括胰腺癌，基因组不稳定性和干细胞生物学等。 In addition 9 Shared Research Resources are included in this application; 6基于BCM的强大功能，以及通过BCMCC的领导力和/或资金创建的3（生物统计学，临床试验支持部门以及病理和组织库）。该中心还建立了一个外展和健康差异办公室，以更好地将我们在该领域的广泛研究专业知识转化为我们在TMC和该地区的合作伙伴和同事之间更加协调的社区行动。 Finally, the BCMCC has been recently blessed with a $100 million philanthropic gift from a wonderful Houston family.该礼物完全致力于支持中心，计划和成员的发展，并促进与其他机构的合作。 Substantial funds will be available for use in the next year even as a long term endowment is created to ensure future stability.因此，CCSG概述了组织结构，杰出的领导力，综合科学研究计划，专家共享资源，社区外展的过程，充分和多样化的患者资源以及建立出色的NCI指定的机构支持 Cancer Center that will benefit the Houston Community and region.